We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

66 hedge funds and large institutions have $17.2M invested in Accelerate Diagnostics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less capital invested

Capital invested by funds: $18M → $17.2M (-$755K)

8% less funds holding

Funds holding: 72 → 66 (-6)

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

72% less call options, than puts

Call options by funds: $8K | Put options by funds: $29K

Holders
66
Holders Change
-6
Holders Change %
-8.33%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
11
Reduced
13
Closed
16
Calls
$8K
Puts
$29K
Net Calls
-$21K
Net Calls Change
+$75K

Top Buyers

1
GAM
Griffin Asset Management
New York
+$1.01M
2
AF
Allworth Financial
California
+$92.6K
3
TC
Tejara Capital
United Kingdom
+$60.1K
4
Northern Trust
Northern Trust
Illinois
+$35.1K
5
UBS Group
UBS Group
Switzerland
+$30.1K

Top Sellers

1
JP Morgan Chase
JP Morgan Chase
New York
-$876K
2
GCP
GSA Capital Partners
United Kingdom
-$437K
3
DKCM
Davidson Kempner Capital Management
New York
-$173K
4
Millennium Management
Millennium Management
New York
-$95.9K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$72.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
HighTower Advisors
26
HighTower Advisors
Illinois
$31K – – –
CIBC Private Wealth Group
27
CIBC Private Wealth Group
Georgia
$27.6K – – –
DC
28
Destiny Capital
Colorado
$26.8K – – –
Squarepoint
29
Squarepoint
New York
$22K +$18.9K +3,147 New
Two Sigma Investments
30
Two Sigma Investments
New York
$22K -$37.9K -6,296 -67%
Charles Schwab
31
Charles Schwab
California
$21.4K – – –
Baird Financial Group
32
Baird Financial Group
Wisconsin
$21K – – –
BBA
33
Baader Bank Aktiengesellschaft
Germany
$20.5K +$22.5K +3,750 New
Mariner
34
Mariner
Kansas
$20K +$17.5K +2,907 New
SWM
35
SeaCrest Wealth Management
New York
$18.8K – – –
Cambridge Investment Research Advisors
36
Cambridge Investment Research Advisors
Iowa
$17K +$6.01K +1,000 +69%
MW
37
Marcum Wealth
Ohio
$15.2K – – –
Bank of America
38
Bank of America
North Carolina
$14.2K -$13.3K -2,209 -52%
GT
39
Glenmede Trust
Pennsylvania
$14K +$12K +2,000 New
RJA
40
Raymond James & Associates
Florida
$12.2K – – –
Bank of New York Mellon
41
Bank of New York Mellon
New York
$10.1K – – –
MWM
42
Modera Wealth Management
New Jersey
$9.1K – – –
TRCT
43
Tower Research Capital (TRC)
New York
$9K +$4.54K +755 +142%
Wolverine Trading
44
Wolverine Trading
Illinois
$9K +$7.99K +1,329 New
IF
45
Ironwood Financial
Arizona
$8.77K – – –
GWM
46
Greenwich Wealth Management
Connecticut
$8K – – –
AAP
47
Arax Advisory Partners
Colorado
$7K – – –
Stifel Financial
48
Stifel Financial
Missouri
$7K – – –
Simplex Trading
49
Simplex Trading
Illinois
$4K +$3.67K +611 New
HGERS
50
Householder Group Estate & Retirement Specialist
Arizona
$4K +$3.85K +640 New
1
2
3 4

AXDX Hedge Fund Activity: Q1 2023 in Review

66 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q1 2023, worth a combined $17.2M — down 4.2% from $18M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AXDX and 10 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 11 added.

The largest buyer was Griffin Asset Management, adding an estimated $1.01M. The largest seller was JP Morgan Chase, cutting an estimated $876K.

  • 66 institutional investors held Accelerate Diagnostics (AXDX) as of Q1 2023, down from 72 in Q4 2022.
  • Funds reported $17.2M of Accelerate Diagnostics stock for Q1 2023, down 4.2% quarter-over-quarter.
  • 10 funds opened new Accelerate Diagnostics positions in Q1 2023 and 16 closed out, a net change of -6 holders.
  • The largest Accelerate Diagnostics buyer in Q1 2023 was Griffin Asset Management, an estimated $1.01M added.
  • The largest Accelerate Diagnostics seller in Q1 2023 was JP Morgan Chase, an estimated $876K sold.

Based on aggregated 13F filings for Q1 2023.